Also known as Allogeneic Transplantation, where the patient receives blood-producing stem cells from another person (a donor), after having confirmed through studies the corresponding level of histo-compatibility between patient and donor. The patient receives chemotherapy with or without radiotherapy. The patient then obtains the stem cells from the other person through a tube that is inserted into a vein. Allogeneic transplant cells are generally not frozen. For the Therefore, doctors can provide the patient with the cells as soon as possible after chemotherapy and/or radiotherapy.
There are 2 types of Allogeneic Transplants, the best type of transplant for each patient depends on age, health and the type of disease being treated. try.
Advantages of Allogeneic Stem Cell Transplantation: the donor's stem cells produce their own immune cells, which could help eliminate any cancer cells left behind after a treatment session. Others The advantages are that the donor can often be asked to donate more stem cells or even white blood cells, if necessary, and stem cells from healthy donors do not contain cancer cells.
Disadvantages of Allogeneic Stem Cell Transplantation: the transplant may not engraft, that is, the stem cells Transplanted from the donor could be prone to dying or being destroyed by the patient's body before settling into the body. bone marrow. Another risk is that the donor's immune system cells are not only dedicated to attacking the cancer cells, but they could also attack healthy cells in the patient's body; this is This is known as graft versus host disease. There is also a very small risk of acquiring certain infections come from the donor's cells, even though donors have to be tested before the donation. Infections that you have had before and that your immune system has under control are a higher risk. These infections usually appear after an allogeneic (allogeneic) transplant because your immune system will be weakened. arrested (suppressed) by medications called immunosuppressants. These infections can cause serious problems and even death.
Allogeneic transplantation is used more frequently to treat certain types of leukemias, lymphomas, multiple myeloma, myelodysplastic syndrome and other types of bone marrow disorders, such as aplastic anemia.
The doctor will recommend an Autotransplant or an Allotransplant based primarily on the disease of the patient. Other factors include: bone marrow health and age or general health.
PATIENT EVALUATION PHASE
Hospitalization (15 days)
Hospitalization in a private room (includes food and nursing care)
Accompanying accommodation with food
Doctor's care for hospitalized patients (includes visiting pass)
Initial evaluation and preparation of clinical history
Comprehensive medical evaluation
Initial specialized hematology consultation in adults/pediatrics
Highly specialized investigations
Hematological
Immunological
Cytogenetics
Molecular
Microbiological (to the patient, and in the cayou are also required from the donor)
Histocompatibility studies on both
Price for patient evaluation phase Allogeneic Stem Cell Transplant: 4 447.00 CUC
Donor evaluation
Hospitalization in a private room (includes food and nursing care)
Doctor's care for hospitalized patients (includes visiting pass)
Initial evaluation and preparation of clinical history
Price of donor evaluation: 3715.00 CUC
Hospitalization (40 days)
Hospitalization in a private isolation room (includes food and nursing care)
Doctor's care for hospitalized patients (includes visiting pass)
Use of medications and complementary evolutionary tests
Execution of the transplant by a specialized medical team
Stem cell implantation
Price for the execution phase of the Allogeneic Stem Cell Transplant Program: 46,436.00 CUC
TOTAL PRICE: 54,598.00 CUC
RELATED TREATMENTS
Autologous Transplant cells Mother. In Leukemias and/or Lymphomas
Medical Services Providers
